N-Acetylcysteine as an Adjunct to Risperidone for Treatment of Negative Symptoms in Patients With Chronic Schizophrenia
Mehdi Farokhnia(National Institutes of Health), Shahin Akhondzadeh(Arak University of Medical Sciences), Anita Azarkolah(Arak University of Medical Sciences), Forod Adinehfar(Razi Hospital), Bahman Salehi(Arak University of Medical Sciences), Farzin Rezaei(Kurdistan University of Medical Sciences), Habibeh Yekehtaz(Arak University of Medical Sciences), Mina Tabrizi(Tehran University of Medical Sciences), Fardin Gharibi(Kurdistan University of Medical Sciences), Seyed-Mohammad-Reza Hosseini(Arak University of Medical Sciences), Omid Mirshafiee(Arak University of Medical Sciences), M Nakhai Moghadam(Kurdistan University of Medical Sciences), Seyed-Mohammad-Hossein Sadeghi(Kurdistan University of Medical Sciences)
Cited by 154
Related Papers
The glucagon-like peptide-1 (GLP-1) analogue semaglutide reduces alcohol drinking and modulates central GABA neurotransmission
|JCI Insight|2023|200
Sex Differences in Opioid and Psychostimulant Craving and Relapse: A Critical Review
|Pharmacological Reviews|2022|155
Comparing the efficacy and safety of<i>Crocus sativus</i>L. with memantine in patients with moderate to severe Alzheimer's disease: a double-blind randomized clinical trial
|Human Psychopharmacology Clinical and Experimental|2014|151
A randomized, double-blind, clinical trial comparing the efficacy and safety of Crocus sativus L. with fluoxetine for improving mild to moderate depression in post percutaneous coronary intervention patients
|Journal of Affective Disorders|2013|135
Education Attainment and Alcohol Binge Drinking: Diminished Returns of Hispanics in Los Angeles
|Behavioral Sciences|2019|131